Sepehr Shakib
- Geriatrics and Gerontology top 0.02%
- Pharmaceutical Practices and Patient Outcomes 55
- Family Practice top 0.1%
- Medication Adherence and Compliance 13
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 13
- Economics and Econometrics top 0.5%
- Health Systems, Economic Evaluations, Quality of Life 25
-
- Chronic Disease Management Strategies 24
-
- Heart Failure Treatment and Management 16
-
- Pharmaceutical studies and practices 12
-
- Drug-Induced Adverse Reactions 11
- Co-authors
- Gillian E. CaugheyLisa Kalisch EllettNashwa MasnoonEmily ReeveMichael S. RobertsIvanka HendrixMichael D. WieseElizabeth E. Roughead
- Journals
- SHILAP Revista de lepidopterología (1 paper)Blood (1 paper)PLoS ONE (3 papers)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Sepehr Shakib
148 papers receiving 5.5k citations
Hit Papers
Peers
Comparison fields: 5 of 159
- Geriatrics and Gerontology 3.2k
- Family Practice 1.0k
- Toxicology 259
- Applied Microbiology and Biotechnology 128
- Economics and Econometrics 1.7k
Countries citing papers authored by Sepehr Shakib
This map shows the geographic impact of Sepehr Shakib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sepehr Shakib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sepehr Shakib more than expected).
Fields of papers citing papers by Sepehr Shakib
This network shows the impact of papers produced by Sepehr Shakib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sepehr Shakib. The network helps show where Sepehr Shakib may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sepehr Shakib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 3 | |
| 9 | 2021 | 5 | |
| 10 | 2021 | 3 | |
| 11 | 2020 | 8 | |
| 12 | 2019 | 39 | |
| 13 | 2019 | 6 | |
| 14 | 2017 | 8 | |
| 15 | 2016 | 144 | |
| 16 | 2016 | 31 | |
| 17 | 2016 | 96 | |
| 18 | 2016 | 13 | |
| 19 | 2014 | 49 | |
| 20 | Caveat anicula! Beware of quiet little old ladies: demographic features, pharmacotherapy, readmissions and survival in a 10-year cohort of patients with heart failure and preserved systolic function. | 2010 | 7 |
About Sepehr Shakib
Sepehr Shakib is a scholar working on Geriatrics and Gerontology, Family Practice and Toxicology, having authored 155 papers that have together received 5.7k indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (55 papers), Health Systems, Economic Evaluations, Quality of Life (25 papers), Chronic Disease Management Strategies (24 papers), Heart Failure Treatment and Management (16 papers), Pharmacovigilance and Adverse Drug Reactions (13 papers), Medication Adherence and Compliance (13 papers), Pharmaceutical studies and practices (12 papers) and Drug-Induced Adverse Reactions (11 papers). The work is most often cited by research in Geriatrics and Gerontology (3.2k citations), Family Practice (1.0k citations) and Toxicology (259 citations). Sepehr Shakib has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Gillian E. Caughey, Lisa Kalisch Ellett, Nashwa Masnoon, Emily Reeve, Michael S. Roberts, Ivanka Hendrix, Michael D. Wiese, Elizabeth E. Roughead, Agnès Vitry and J. Simon Bell. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.